AX PHARMACEUTICAL- buserelin acetate powder

Pays: États-Unis

Langue: anglais

Source: NLM (National Library of Medicine)

Ingrédients actifs:

BUSERELIN ACETATE (UNII: 13U86G7YSP) (BUSERELIN - UNII:PXW8U3YXDV)

Disponible depuis:

AX Pharmaceutical Corp

DCI (Dénomination commune internationale):

BUSERELIN ACETATE

Composition:

BUSERELIN .99 g in 1 g

Mode d'administration:

NOT APPLICABLE

Statut de autorisation:

Bulk Ingredient For Animal Drug Compounding

Résumé des caractéristiques du produit

AX PHARMACEUTICAL- BUSERELIN ACETATE POWDER
AX PHARMACEUTICAL CORP
----------
AX PHARMACEUTICAL
AX Pharmaceutical Corp
buserelin acetate powder
PRODUCT INFORMATION
PRODUCT T YPE
BULK INGREDIENT
ITE M CODE (SOURCE )
NDC:6 2157-39 1
ROUTE OF ADMINISTRATION
NOT APPLICABLE
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
BUSERELIN ACETATE (UNII: 13U8 6 G7YSP) (BUSERELIN - UNII:PXW8 U3YXDV)
BUSERELIN
.9 9 g in 1 g
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
WATER (UNII: 0 59 QF0 KO0 R)
PRODUCT CHARACTERISTICS
COLOR
white
S CORE
S HAP E
S IZ E
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:6 2157-39 1-0 1
1 g in 1 VIAL
0 2/23/20 17
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH
CITA TIO N
MARKE TING START
DATE
MARKE TING END
DATE
bulk ingredient fo r animal drug
c o mpo unding
0 2/23/20 17
LABELER -
AX Pharmaceutical Corp (202924858)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
AX Pharmaceutical Co rp
20 29 248 58
pack(6 2157-39 1) , relabel(6 2157-39 1)
Revised: 2/2017